Eczema News and Research

Latest Eczema News and Research

Immune system protein LL-37 critical in controlling replication of vaccinia virus

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have identified a defect in the immune response of people with the skin condition atopic dermatitis that puts them at risk of developing serious complications following smallpox vaccination.

23 Mar 2006

Potential therapeutic targets against serious side effects of smallpox vaccine

Smallpox is considered a potential terrorist weapon, but millions of people in the United States are currently advised not to get a vaccine to the disease because they are susceptible to developing a severe adverse reaction.

23 Mar 2006

Gene discovered that causes dry skin and leads to eczema and asthma

Experts, lead by the University of Dundee, have discovered the gene which causes genetic skin conditions affecting millions of people.

21 Mar 2006

Hand eczema caused by soaps in the workplace may lead to unemployment or prolonged sick leaves

Hand eczema caused by soaps and other irritants in the workplace may lead to unemployment or prolonged sick leaves from work for some individuals, according to an article in the March issue of Archives of Dermatology.

21 Mar 2006

Researchers to investigate links between asthma and genes

Professor Bill Cookson and Dr Miriam Moffatt, formerly at the University of Oxford, have joined Imperial's National Heart and Lung Institute to further develop the genetic research there, particularly focusing on how genes influence the development of asthma.

14 Mar 2006

Study shows new atopic dermatitis therapy significantly delays onset of flares

Stiefel Laboratories, the world's largest independent pharmaceutical company specializing in dermatology, announced that a recent study shows MimyX Cream extends the remission period of atopic dermatitis (AD) by 48 percent when used in conjunction with an emollient compared to emollient alone.

6 Mar 2006

American Academy of Dermatology disagrees with eczema medication action taken by FDA

The American Academy of Dermatology (Academy) has issued a statement in response to the U.S. Food and Drug Administration’s (FDA) announcement that a black box warning will be added to the labeling and a medication guide will be distributed for the topical calcineurin inhibitors (TCIs), pimecrolimus and tacrolimus.

23 Jan 2006

Black box warnings for two eczema creams

Food and Drug Administration officials in the U.S. have announced that two prescription creams to treat eczema will now carry strong warnings about the possible risk of skin cancer, lymphoma and other cancers.

22 Jan 2006

Anthroposophic lifestyle reduces the risk of allergic disease in children

Certain features of the anthroposophic lifestyle, such as restrictive use of antibiotics and fever antipyretics, reduce the risk of allergic disease in children, according to a new study.

10 Jan 2006

Botox - other applications

While botulinum toxin A, or BTXA, is widely known for its use in dermatology and aesthetic medicine, a review article in the Journal of Cosmetic Dermatology explores the drug’s other successful applications.

12 Dec 2005

Researchers identify gene defect in mice that causes cyclical hair loss and skin cancer

Researchers at Jefferson Medical College and at the Wadsworth Center in New York have identified a gene defect in mice resulting in a range of abnormalities, from cyclical hair loss and skin cancer to severe problems in normal skin development.

4 Oct 2005

Pharmacists can drastically reduce patients worries about using steroids

For those people who suffer from eczema, the use of topical corticosteroids is high up on their list of concerns: How should they be used? And are they safe?

26 Sep 2005

More than fifty percent of the U.S. population tested positive to one or more allergens

The new findings, based on data from the third National Health and Nutrition Examination Survey (NHANES III), shows that 54.3% of individuals aged 6-59 years old had a positive skin test response to at least one of the 10 allergens tested.

4 Aug 2005

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

Glioblastoma multiforme (GBM) affects three out of 100,000 people, a rate that quadruples to 13 out 100,000 among people who are 65 and older. The average five-year survival rate from the time of diagnosis for GBM is only 3.3 percent, and is lower for people 65 and older.

15 Jul 2005

Powerful steroids could be avoided in many cases of childhood eczema

An expert at the University of Sheffield will be talking about the causes for the increased incidence of eczema in children in a Channel Four documentary, Allergic to Everything on Thursday 30 June at 9pm.

27 Jun 2005

Novel method to reduce cat allergic reactions

Scientists have discovered a novel method to reduce cat allergic reactions by topping up the immune cells responsible for controlling them.

6 Apr 2005

Tumour Necrosis Factor alpha (TNF-alpha) blocking agents cause skin disease

Members of the second most important family of drugs used to treat rheumatoid arthritis can cause serious dermatological conditions in a quarter of patients under treatment, reveals a study published in the journal Arthritis Research and Therapy.

3 Apr 2005

Study looks at infants and chronic nighttime crying

Two University of Maine researchers working in conjunction with colleagues in Japan have found links between infant and child sleeping arrangements and the phenomenon of "yonaki," or nighttime crying.

3 Apr 2005

Protopic and Elidel may cause cancer

Protopic and Elidel, two treatments for eczema approved in 2000 and 2001, have now been found to cause cancer in three different animal species.

13 Mar 2005

When breast augmentation or reduction cases are medically necessary

Traditionally, breast augmentation and reduction surgeries are defined by health insurers as cosmetic. It's a definition that often puts patients at odds with health insurers. Payers have difficulty deciding if breast augmentation or reduction cases are medically necessary.

22 Feb 2005